Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis
Rebecca M. Baron(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Bonna Ith(Maine Farmland Trust), Ana P. Castaño(Harvard University), Alvaro A. Macias(University of California San Diego), Raymond Reeves(Washington State University), Matthew D. Layne(Boston University), Sailaja Ghanta(Brigham and Women's Hospital), Shaw‐Fang Yet(Unknown), Dario F. Riascos‐Bernal(Albert Einstein College of Medicine), Scott L. Schissel(Columbia University), Xiaoli Liu(Qingdao Agricultural University), Silvia López-Guzmán(Brigham and Women's Hospital), Min-Young Kwon(University of Ulsan), James A. Lederer(Brigham and Women's Hospital)
Cited by 14
Related Papers
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710